Clinical Research Directory
Browse clinical research sites, groups, and studies.
GLP_1 RA Ultrasound Study
Sponsor: Children's Hospital Medical Center, Cincinnati
Summary
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.
Official title: Assessment of Gastric Contents in Patients Taking Glucagon-Like Peptide-1 Receptor Agonists: a Prospective Observational Cross-sectional Study
Key Details
Gender
All
Age Range
10 Years - 25 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-07-08
Completion Date
2026-07
Last Updated
2024-11-07
Healthy Volunteers
Yes
Conditions
Interventions
Glucagon-Like Peptide-1 receptor agonists
GLP-1 RAs: Glucagon like peptide-1 receptor agonists, this includes patients who are on Liraglutide, Semaglutide, Dulaglutide and Tirzepatide.Tirzepatide which is a combined GLP-1 RA/glucose-dependent insulinotropic polypeptide (GIP) agonist is included as a part of GLP-1 RAs.
Point of Care Gastric Ultrasound
A gastric ultrasound following a standard NPO period to determine gastric contents and risk of aspiration during surgery.
Locations (1)
Cincinnati Children's Hospital
Cincinnati, Ohio, United States